Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease
Dysfunction of mitochondrial complex I is associated with a wide spectrum of
neurodegenerative disorders, including Parkinson's disease (PD). In rodents, inhibition of …
neurodegenerative disorders, including Parkinson's disease (PD). In rodents, inhibition of …
Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond
Significance: Activation of mitochondrion-dependent programmed cell death (PCD)
pathways is instrumental to the demise of substantia nigra pars compacta dopaminergic …
pathways is instrumental to the demise of substantia nigra pars compacta dopaminergic …
[HTML][HTML] Glucose metabolism impairment in Parkinson's disease
C Dai, C Tan, L Zhao, Y Liang, G Liu, H Liu… - Brain research …, 2023 - Elsevier
Impairments in systematic and regional glucose metabolism exist in patients with
Parkinson's disease (PD) at every stage of the disease course, and such impairments are …
Parkinson's disease (PD) at every stage of the disease course, and such impairments are …
Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
Parkinson Study Group PRECEPT Investigators - Neurology, 2007 - AAN Enterprises
Background: CEP-1347 inhibits mixed lineage kinases that activate apoptotic pathways
implicated in the pathogenesis of Parkinson disease (PD). CEP-1347 enhances neuronal …
implicated in the pathogenesis of Parkinson disease (PD). CEP-1347 enhances neuronal …
The molecular pathway of p75 neurotrophin receptor (p75NTR) in Parkinson's disease: The way of new inroads
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disease of the
brain. PD is characterized by motor and non-motor symptoms. The p75 neurotrophin …
brain. PD is characterized by motor and non-motor symptoms. The p75 neurotrophin …
Integrated molecular landscape of Parkinson's disease
CJHM Klemann, GJM Martens, M Sharma… - npj Parkinson's …, 2017 - nature.com
Parkinson's disease is caused by a complex interplay of genetic and environmental factors.
Although a number of independent molecular pathways and processes have been …
Although a number of independent molecular pathways and processes have been …
Targeting disease through novel pathways of apoptosis and autophagy
K Maiese, ZZ Chong, YC Shang… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Apoptosis and autophagy impact cell death in multiple systems of the body.
Development of new therapeutic strategies that target these processes must address their …
Development of new therapeutic strategies that target these processes must address their …
[HTML][HTML] Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma
G Tezel, X Yang, J Cai - Investigative ophthalmology & visual …, 2005 - arvojournals.org
purpose. Based on the evidence of an amplified production of reactive oxygen species
(ROS) during glaucomatous neurodegeneration, proteomic analysis was performed to …
(ROS) during glaucomatous neurodegeneration, proteomic analysis was performed to …
Spatial distribution of Bax and Bcl‐2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation?
O Verborgt, NA Tatton, RJ Majeska… - Journal of bone and …, 2002 - academic.oup.com
Osteocyte apoptosis appears to play a key role in the mechanism by which osteoclastic
resorption activity targets bone for removal, because osteocyte apoptosis occurs in highly …
resorption activity targets bone for removal, because osteocyte apoptosis occurs in highly …
[HTML][HTML] The therapeutic role of minocycline in Parkinson's disease
Minocycline, a semisynthetic tetracycline-derived antibiotic, has been shown to exert anti-
apoptotic, anti-inflammatory, and antioxidant effects. Furthermore, there is rapidly growing …
apoptotic, anti-inflammatory, and antioxidant effects. Furthermore, there is rapidly growing …